These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31686340)

  • 1. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer.
    Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L
    Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
    Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
    J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Volume Lymph Node Metastases in Endometrial Carcinoma.
    Clinton LK; Kondo J; Carney ME; Tauchi-Nishi P; Terada K; Shimizu D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1165-1170. PubMed ID: 28604450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node intraoperative analysis in endometrial cancer.
    Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
    Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
    Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
    De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer with positive sentinel lymph nodes: pathologic characteristics of metastases as predictors of extent of lymphatic dissemination and prognosis.
    Dinoi G; Ghoniem K; Huang Y; Zanfagnin V; Cucinella G; Langstraat C; Glaser G; Kumar A; Weaver A; McGree M; Fanfani F; Scambia G; Mariani A
    Int J Gynecol Cancer; 2024 Aug; 34(8):1172-1182. PubMed ID: 38658020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
    Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
    St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
    Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
    Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
    J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.